Jian-ping Gong Selected Research

Jian-ping Gong Research Topics

Disease

7	Neoplasms (Cancer) 02/2013 - 11/2006
5	Reperfusion Injury 09/2012 - 03/2005
4	Carcinoma (Carcinomatosis) 02/2013 - 12/2004
4	Hepatocellular Carcinoma (Hepatoma) 10/2011 - 10/2004
3	Fibrosis (Cirrhosis) 10/2013 - 10/2011
2	Neoplasm Metastasis (Metastasis) 02/2013 - 02/2013
2	Inflammation (Inflammations) 07/2011 - 05/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2014
1	Infections 09/2014
1	Lymphatic Metastasis 02/2013
1	Stomach Neoplasms (Stomach Cancer) 02/2013
1	Carcinogenesis 10/2011
1	Colonic Neoplasms (Colon Cancer) 05/2010
1	Chronic Hepatitis B 02/2009
1	Thrombosis (Thrombus) 05/2008
1	Hemorrhage 05/2008
1	Ulcer 05/2008
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2008
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2008
1	Breast Neoplasms (Breast Cancer) 03/2007
1	Nasopharyngeal Carcinoma 11/2006
1	Endotoxemia 10/2003

Drug/Important Bio-Agent (IBA)

4	Messenger RNA (mRNA)IBA 10/2011 - 10/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 10/2003
3	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2012 - 11/2006
3	LipopolysaccharidesIBA 05/2009 - 03/2005
2	NF-kappa B (NF-kB)IBA 09/2012 - 03/2005
2	EpitopesIBA 05/2012 - 06/2011
2	AntigensIBA 05/2012 - 06/2011
2	Peptides (Polypeptides)IBA 05/2012 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 04/2010
2	Liver X ReceptorsIBA 07/2011 - 05/2009
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2006 - 09/2006
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2006 - 03/2005
2	EndotoxinsIBA 09/2006 - 10/2003
1	Ustekinumab (CNTO 1275)FDA Link 09/2014
1	Therapeutic UsesIBA 09/2014
1	Bromodeoxyuridine (BrdU)IBA 10/2013
1	ferric oxide (iron oxide)IBA 10/2013
1	CyclinsIBA 02/2013
1	CarbonIBA 01/2013
1	Taurine FDA Link 09/2012
1	HLA-A Antigens (HLA-A)IBA 05/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2011
1	HLA-A24 AntigenIBA 06/2011
1	Nylons (Nylon)IBA 06/2011
1	Cyclin D1IBA 05/2010
1	Thymidine KinaseIBA 04/2010
1	T0901317IBA 05/2009
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2009
1	AnticoagulantsIBA 05/2008
1	Saline SolutionIBA 05/2008
1	PlasticsIBA 05/2008
1	salicylhydroxamic acid (SHAM)IBA 05/2008
1	Chemokine CCL3IBA 05/2008
1	RNA (Ribonucleic Acid)IBA 03/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	EndostatinsIBA 03/2007
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 03/2007
1	Indicators and Reagents (Reagents)IBA 03/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2007
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Caspase 3 (Caspase-3)IBA 11/2006
1	Small Interfering RNA (siRNA)IBA 09/2006
1	Toll-Like Receptor 4IBA 03/2005
1	Interleukin-1 (Interleukin 1)IBA 03/2005
1	Lipopolysaccharide ReceptorsIBA 03/2005
1	PeplomycinIBA 12/2004
1	Thymidine Monophosphate (TMP)IBA 10/2004
1	tetramethylpyrazineIBA 10/2004
1	lipopolysaccharide-binding proteinIBA 10/2003
1	Interleukin-6 (Interleukin 6)IBA 10/2003

Therapy/Procedure

2	Therapeutics 09/2014 - 05/2008
1	Lymph Node Excision (Lymph Node Dissection) 02/2013
1	Liver Transplantation 09/2012
1	Immunotherapy 06/2011
1	Microspheres (Microsphere) 06/2011
1	Microbubbles 04/2010
1	Subcutaneous Injections 05/2008
1	Thrombolytic Therapy 05/2008
1	Drug Therapy (Chemotherapy) 03/2007